14.45
+0.35
+(2.48%)
At close: 9:28:55 AM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-99,699.00
-99,699.00
-82,799.00
-85,030.00
-156,298.00
Investing Cash Flow
18,784.00
18,784.00
56,406.00
-85,287.00
177,336.00
Financing Cash Flow
62,862.00
62,862.00
-2,511.00
245,000.00
--
End Cash Position
127,256.00
127,256.00
144,225.00
167,706.00
95,203.00
Capital Expenditure
-4,387.00
-4,387.00
-13,501.00
-17,914.00
-7,518.00
Issuance of Capital Stock
65,473.00
65,473.00
--
245,000.00
--
Free Cash Flow
-104,086.00
-104,086.00
-96,300.00
-102,944.00
-163,816.00
12/31/2020 - 10/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4197.TWO Visgeneer Inc.
9.78
0.00%
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
6848.TWO RBC Bioscience Corporation
19.05
0.00%
6709.TWO Advagene Biopharma Co., Ltd.
20.25
+0.25%
6814.TWO Lukas Biomedical Inc.
27.60
0.00%
6810.TWO Bio Preventive Medicine Corp.
30.00
+0.17%
4170.TWO VBI
14.10
+0.71%
7754.TWO AnnJi
32.55
-3.70%
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
4732.TWO NatureWise Biotech & Medicals Corporation
23.20
+0.87%